Revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Alterity Therapeutics Ltd (ATHE)
Price$3.75Cached quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $8.1M | $4.3M | $3.9M | $5.1M | $4.5M | $139,846 | $5.1M | $201,174 | $132,396 | $142,657 |
| Research & development | $17.6M | $14.4M | $18.6M | $13.2M | $14.7M | $12.3M | $10.1M | $13.0M | $6.7M | $5.7M | $9.6M |
| Operating expenses | $25.1M | $12.5M | $19.6M | $14.7M | $15.1M | — | — | — | — | — | — |
| Operating income | −$25.1M | −$12.5M | −$19.6M | −$14.7M | −$15.1M | — | — | — | — | — | — |
| Operating margin | — | −154.07% | −457.51% | −372.59% | −295.30% | — | — | — | — | — | — |
| EBITDA | −$25.0M | −$12.3M | −$19.5M | −$14.6M | −$15.1M | — | — | — | — | — | — |
| EBITDA margin | — | −152.35% | −454.07% | −369.99% | −294.25% | — | — | — | — | — | — |
| Net income | −$23.4M | −$12.1M | −$19.1M | −$13.8M | −$12.8M | −$15.3M | −$13.5M | −$12.3M | −$8.3M | −$7.5M | −$7.7M |
| Net profit margin | — | −150.20% | −446.01% | −351.06% | −250.62% | −339.76% | −9,622.58% | −243.84% | −4,108.75% | −5,696.60% | −5,418.28% |
| Basic EPSper basic share | -A$1.33 | -A$0.00 | -A$0.01 | -A$0.57 | -A$0.53 | -A$0.90 | -A$1.50 | -A$2.00 | -A$0.02 | -A$0.01 | -A$0.01 |
| Diluted EPSper diluted share | -A$1.33 | -A$0.00 | -A$0.01 | -A$0.57 | -A$0.53 | -A$0.90 | -A$1.50 | -A$2.00 | -A$0.02 | -A$0.01 | -A$0.01 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Twin Lakes Capital Management, LLC | 139.26K |
MORGAN STANLEY | 63.07K |
GREENLEAF TRUST | 62K |
HB Wealth Management, LLC | 58.46K |
CITADEL ADVISORS LLC | 37.6K |
HRT FINANCIAL LP | 17.29K |
BNP PARIBAS FINANCIAL MARKETS | 10.24K |
GAMMA Investing LLC | 2.31K |
RHUMBLINE ADVISERS | 2.01K |
ACADIAN ASSET MANAGEMENT LLC | 1.86K |
Providence Capital Advisors, LLC | 200 |
Integrated Wealth Concepts LLC | 73 |
OSAIC HOLDINGS, INC. | 68 |
Blue Trust, Inc. | 40 |
Farther Finance Advisors, LLC | 39 |
CoreCap Advisors, LLC | 21 |
Steward Partners Investment Advisory, LLC | 6 |
UBS Group AG | 5 |
DANSKE BANK A/S | 1 |
CITIGROUP INC | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data